Innate Pharma S.A. (NASDAQ:IPHA) Q3 2022 Earnings Call Transcript November 14, 2022
Operator: Hello, and thank you for standing by. My name is Regina and I will be your conference operator today. At this time I would like to welcome everyone to the Innate Pharma publication of revenue for Third Quarter 2022 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks there will be a question-and-answer session. I would now like to turn the...
